Long-term outcome of sinusoidal obstruction syndrome secondary to hematopoietic stem cell transplantation.
文献摘要
Background & aims Sinusoidal obstruction syndrome (SOS) is a potentially severe complication of conditioning regimens in hematopoietic stem cell transplantation (HSCT). Its long-term outcome is unknown. The aim of this study was to investigate the long-term liver outcome of patients with SOS. Methods We retrospectively analyzed the outcome of all patients with histologically proven SOS related to HSCT conditioning who survived 6 months or more after HSCT. Twenty-two patients with SOS were included. Results Median follow-up after SOS was 6.1 years. During this period, 10 patients (45%) developed signs of portal hypertension and eight (36%) of them had liver-related complications (ascites, n = 8; spontaneous bacterial peritonitis, n = 1; hepatic encephalopathy, n = 3; variceal bleeding, n = 3). Cumulative incidence of signs of portal hypertension was 27% at 3 years. Patients who developed signs of portal hypertension were less likely to have received defibrotide (hazard ratio: 0.096; p Conclusions Development of signs of portal hypertension and liver-related complications are common in the long-term after SOS following HSCT, especially when patients did not receive defibrotide, and this affects patients' survival. Features consistent with a porto-sinusoidal vascular disorder may be seen in liver histology in a subset of patients at the long-term follow-up after SOS. Impact and implications Long-term liver outcome of SOS following conditioning regimens in HSCT is unknown. This study demonstrates that signs of portal hypertension and liver-related complications are common during long-term follow-up after SOS following HSCT. Treatment of SOS with defibrotide seems to be associated with a lower risk of developing portal hypertension. Liver histology at the long-term follow-up after SOS may show features consistent with porto-sinusoidal vascular disorder. SOS following HSCT might thus be removed from the porto-sinusoidal vascular disorder exclusion criteria.